This page shows the latest open letter news and features for those working in and with pharma, biotech and healthcare.
An open letter to the incoming President of the United States on COVID-19 messaging priorities.
In an open letter published on 16 October, Pfizer’s chief executive officer Albert Bourla said that the company is hoping to submit its BioNTech-partnered COVID-19 vaccine candidate for
Pfizer is expecting the first efficacy data from its phase 3 trial of BNT162b2, with chief executive officer Albert Bourla revealing in an open letter published last week that the company
However, in an open letter published last week, Bourla said that the companies will not submit the vaccine for emergency use authorisation in the US until the third week of November.
In an open letter published on Friday, Bourla said that Pfizer will not submit the vaccine candidate for emergency use authorisation in the US until the third week of November. ... In his open letter, Bourla added that “there are three key areas where,
In an open letter to the BPNA, parents of children with epilepsy have accused the BPNA of ignoring the change in the law as well as the advice of the UK
More from news
Approximately 0 fully matching, plus 32 partially matching documents found.
shaming’. However, this didn’t just come from body positivity campaigners – academics and nutritionists from respected institutions also warned in an open letter that the campaign may make people with obesity
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...